NCT00228917
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +22 more
- Locations
-
- GSK Investigational Site City of Muntinlupa, Philippines
- GSK Investigational Site Bangkok, Thailand
Clinical trial condition
Tetanus
Explore clinical trials studying Tetanus. Study availability and eligibility vary by location and protocol.
225 public trials
6 recruiting studies
Tetanus trial results
NCT00148941
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Antioch, California, United States
- GSK Investigational Site Daly City, California, United States
- GSK Investigational Site Fairfield, California, United States
NCT01171989
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Bydgoszcz, Poland
- GSK Investigational Site Dębica, Poland
- GSK Investigational Site Krakow, Poland
- GSK Investigational Site Krakow, Poland
NCT01577732
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
- Locations
-
- GSK Investigational Site Haiphong, Vietnam
NCT02853929
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +37 more
- Locations
-
- GSK Investigational Site Carlton, Victoria, Australia
- GSK Investigational Site Calgary, Alberta, Canada
- GSK Investigational Site Halifax, Nova Scotia, Canada
- GSK Investigational Site Montreal, Quebec, Canada
NCT00548171
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
- Locations
-
- GSK Investigational Site Westmead, New South Wales, Australia
NCT03950986
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +19 more
- Locations
-
- Atlanta VA Medical Center Decatur, Georgia, United States
NCT00352963
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
- Locations
-
- GSK Investigational Site Alcorcón, Spain
- GSK Investigational Site Almeira, Spain
- GSK Investigational Site Badalona, Spain
- GSK Investigational Site Barcelona, Spain
Completed
Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.
NCT00835237
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
- Locations
-
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site DeLand, Florida, United States
- GSK Investigational Site West Palm Beach, Florida, United States
NCT00970307
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Bydgoszcz, Poland
- GSK Investigational Site Dębica, Poland
- GSK Investigational Site Krakow, Poland
- GSK Investigational Site Krakow, Poland